UCBG 2-04: Long-term results of the PACS 04 trial evaluating adjuvant epirubicin plus docetaxel in node-positive breast cancer and trastuzumab in the human epidermal growth factor receptor 2–positive subgroup
Titel:
UCBG 2-04: Long-term results of the PACS 04 trial evaluating adjuvant epirubicin plus docetaxel in node-positive breast cancer and trastuzumab in the human epidermal growth factor receptor 2–positive subgroup
Auteur:
D'Hondt, Véronique Canon, Jean-Luc Roca, Lise Levy, Christelle Pierga, Jean-Yves Le Du, Fanny Campone, Mario Desmoulins, Isabelle Goncalves, Anthony Debled, Marc Rios, Maria Ferrero, Jean-Marc Serin, Daniel Hardy-Bessard, Anne-Claire Piot, Gilles Brain, Etienne Dohollou, Nadine Orfeuvre, Hubert Lemonnier, Jerome Roché, Henri Delaloge, Suzette Dalenc, Florence